Prevention of bisphosphonate-related osteonecrosis of the jaws in patients with prostate cancer treated with zoledronic acid – A prospective study over 6 years-Reference-Cited by-同舟云学术

Prevention of bisphosphonate-related osteonecrosis of the jaws in patients with prostate cancer treated with zoledronic acid – A prospective study over 6 years

Published:2016-10 Issue:10 Volume:44 Page:1689-1693
ISSN:1010-5182
Container-title:Journal of Cranio-Maxillofacial Surgery
language:en
Short-container-title:Journal of Cranio-Maxillofacial Surgery

Author:

Mücke Thomas^ORCID,Deppe Herbert,Hein Jana,Wolff Klaus-Dietrich,Mitchell David A.,Kesting Marco R.,Retz Margitta,Gschwend Jürgen E.,Thalgott Mark

Publisher

Elsevier BV

Subject

Otorhinolaryngology,Oral Surgery,Surgery

Reference44 articles.

1. Bisphosphonate-associated osteonecrosis of the jaw;Abu-Id;Mund Kiefer Gesichtschir,2006

2. Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors;Badros;J Clin Oncol,2006

3. Natural history of osteonecrosis of the jaw in patients with multiple myeloma;Badros;J Clin Oncol,2008

4. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors;Bamias;J Clin Oncol,2005

5. Incidence of bisphosphonate-related osteonecrosis of the jaw in high-risk patients undergoing surgical tooth extraction;Bodem;J Craniomaxillofac Surg,2015

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How we manage medication-related osteonecrosis of the jaw;European Journal of Medical Research;2024-08-02

2. A multifaceted role of bisphosphonates from palliative care to anti-cancer therapy in solid tumors;Journal of Oncology Pharmacy Practice;2024-07-26

3. Medication-related osteonecrosis of the jaw: evolving research for multimodality medical management;Supportive Care in Cancer;2024-03-05

4. Italian position paper (SIPMO‐SICMF) on medication‐related osteonecrosis of the jaw (MRONJ);Oral Diseases;2024-02-05

5. Survey of the association between tooth extraction and development of medication-related osteonecrosis of the jaw in patients undergoing cancer treatment with bone-modifying agents;Oral and Maxillofacial Surgery;2024-02-01